Rucaparib, Ramucirumab and Nivolumab in Patients Who Have Had Treatment for Gastric and Esophageal Adenocarcinoma
about
Rucaparib, Ramucirumab and Nivolumab in Patients Who Have Had Treatment for Gastric and Esophageal Adenocarcinoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Rucaparib, Ramucirumab and Niv ...... and Esophageal Adenocarcinoma
@en
Rucaparib, Ramucirumab and Niv ...... and Esophageal Adenocarcinoma
@nl
type
label
Rucaparib, Ramucirumab and Niv ...... and Esophageal Adenocarcinoma
@en
Rucaparib, Ramucirumab and Niv ...... and Esophageal Adenocarcinoma
@nl
prefLabel
Rucaparib, Ramucirumab and Niv ...... and Esophageal Adenocarcinoma
@en
Rucaparib, Ramucirumab and Niv ...... and Esophageal Adenocarcinoma
@nl
P1050
P1476
A Phase I/II Trial of Rucapari ...... ophageal Adenocarcinoma (RiME)
@en
P1813
RiME
@en
P3098
NCT03995017
P4844
P580
2019-07-01T00:00:00Z
P582
2021-05-01T00:00:00Z